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Abstract
Background
Neurodevelopmental conditions commonly coexist in children, but compared to adults,
childhood multimorbidity attracts less attention in research and clinical practice. We previ-
ously reported that children treated for attention deficit hyperactivity disorder (ADHD) and
depression have more school absences and exclusions, additional support needs, poorer
attainment, and increased unemployment. They are also more likely to have coexisting con-
ditions, including autism and intellectual disability. We investigated prevalence of neurode-
velopmental multimorbidity (�2 conditions) among Scottish schoolchildren and their
educational outcomes compared to peers.
Methods and findings
We retrospectively linked 6 Scotland-wide databases to analyse 766,244 children (390,290
[50.9%] boys; 375,954 [49.1%] girls) aged 4 to 19 years (mean = 10.9) attending Scottish
schools between 2009 and 2013. Children were distributed across all deprivation quintiles
(most to least deprived: 22.7%, 20.1%, 19.3%, 19.5%, 18.4%). The majority (96.2%) were
white ethnicity. We ascertained autism spectrum disorder (ASD) and intellectual disabilities
from records of additional support needs and ADHD and depression through relevant
encashed prescriptions. We identified neurodevelopmental multimorbidity (�2 of these con-
ditions) in 4,789 (0.6%) children, with ASD and intellectual disability the most common com-
bination. On adjusting for sociodemographic (sex, age, ethnicity, deprivation) and maternity
(maternal age, maternal smoking, sex-gestation–specific birth weight centile, gestational
age, 5-minute Apgar score, mode of delivery, parity) factors, multimorbidity was associated
with increased school absenteeism and exclusion, unemployment, and poorer exam attain-
ment. Significant dose relationships were evident between number of conditions (0, 1,�2)
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and the last 3 outcomes. Compared to children with no conditions, children with 1 condition,
and children with 2 or more conditions, had more absenteeism (1 condition adjusted inci-
dence rate ratio [IRR] 1.28, 95% CI 1.27–1.30, p < 0.001 and 2 or more conditions adjusted
IRR 1.23, 95% CI 1.20–1.28, p < 0.001), greater exclusion (adjusted IRR 2.37, 95% CI
2.25–2.48, p < 0.001 and adjusted IRR 3.04, 95% CI 2.74–3.38, p < 0.001), poorer attain-
ment (adjusted odds ratio [OR] 3.92, 95% CI 3.63–4.23, p < 0.001 and adjusted OR 12.07,
95% CI 9.15–15.94, p < 0.001), and increased unemployment (adjusted OR 1.57, 95% CI
1.49–1.66, p < 0.001 and adjusted OR 2.11, 95% CI 1.83–2.45, p < 0.001). Associations
remained after further adjustment for comorbid physical conditions and additional support
needs. Coexisting depression was the strongest driver of absenteeism and coexisting
ADHD the strongest driver of exclusion. Absence of formal primary care diagnoses was a
limitation since ascertaining depression and ADHD from prescriptions omitted affected chil-
dren receiving alternative or no treatment and some antidepressants can be prescribed for
other indications.
Conclusions
Structuring clinical practice and training around single conditions may disadvantage children
with neurodevelopmental multimorbidity, who we observed had significantly poorer educa-
tional outcomes compared to children with 1 condition and no conditions.
Author summary
Why was this study done?
• Children with neurodevelopmental conditions experience difficulties at school.
• Multiple neurodevelopmental conditions commonly coexist together.
• We investigated prevalence of neurodevelopmental multimorbidity in Scottish school-
children and their educational outcomes compared to peers.
What did the researchers do and find?
• We linked Scotland-wide health and education data together to identify neurodevelop-
mental multimorbidity among children attending school in Scotland between 2009 and
2013, inclusive.
• We identified children treated for depression, attention deficit hyperactivity disorder
(ADHD), autism, and intellectual disability and defined comorbidity as 2 or more of
those conditions existing together.
• Compared to children with no conditions, children with 1 condition, and children with
2 or more of these conditions, experienced increased school absenteeism and exclusion,
poorer exam attainment, and increased unemployment.
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What do these findings mean?
• Structuring clinical practice and training around single conditions may disadvantage
children with multimorbidity, who we observed in our study to have significantly
increased risk of poor educational outcomes compared to children with 1 condition and
no conditions.
Introduction
Multimorbidity in adulthood has attracted increasing recognition and was highlighted by the
Academy of Medical Sciences as a global priority for health research [1]. In comparison, child-
hood multimorbidity has received little attention. Indeed, children with neurodevelopmental
disorders such as attention deficit hyperactivity disorder (ADHD) [2–4], autism spectrum dis-
order (ASD) [5, 6–8], depression [9, 10], and intellectual disability [11–13] appear to be at par-
ticular risk of multimorbidity, and in 2010, the phrase Early Symptomatic Syndromes Eliciting
Neurodevelopmental Clinical Examination (ESSENCE) was first used in recognition of the fre-
quent coexistence of childhood neurodevelopmental disorders [14]. Pre-school children with
ASD, for example, have been reported to have a mean of 3.2 coexisting neurodevelopmental
disorders, including ADHD and intellectual disability [5], and comorbidities such as anxiety
and obsessive-compulsive disorder (OCD) are also common [6–8]. Common conditions exist-
ing alongside ADHD include depression, intellectual disability, anxiety, ASD, conduct disor-
der, oppositional defiant disorder, tics, and Tourette [2–4, 15–17]. Studies on children with
intellectual disabilities have reported a range of comorbid internalizing and externalizing men-
tal health conditions such as ADHD and depression [11–13]. Depression commonly occurs
with various anxiety disorders [9, 10]. Furthermore, there is emerging evidence of pleiotropy
[18]. This underlying predisposition to multiple conditions is important because clinical train-
ing, clinical pathways and interventions tend to be structured around single disorders. For
example, in the United Kingdom, in “core” psychiatric training (the first 3 years of psychiatric
training) and in “higher” specialist training in child and adolescent psychiatry (a further 3
years’ training to complete specialist training and be eligible for a consultant position), the
core intended learning objectives that the Royal College of Psychiatrists require to be met spec-
ify learning on all the individual common psychiatric conditions, comorbidity with physical
conditions, but not comorbidity of psychiatric conditions [19, 20]. This incongruent approach
may fail to fully recognise and address these children’s complex needs and their propensity to
disease–disease, drug–disease, and drug–drug interactions.
Chronic neurodevelopmental disorders have been associated with poorer school outcomes
[21]; however, previous studies reporting educational outcomes for children with neurodeve-
lopmental disorders have tended to focus only on individual conditions such as ASD [22, 23],
ADHD [24, 25], depression [26, 27, 28], and intellectual disability [29, 30]. As a result, there is
a paucity of literature reporting outcomes for children with coexisting neurodevelopmental
conditions [31–33]. Previous studies investigating singular or comorbid neurodevelopmental
conditions have used small cohorts, with only a handful of larger studies focussing on the edu-
cational outcomes associated with single conditions [24, 28, 34]. Small studies that have inves-
tigated school outcomes of children with co-occurring conditions have mainly focussed on
comorbid ADHD with respect to academic attainment, with few investigating school grades
and most using battery tests [32] or parental, teacher, or pupil feedback [31, 33, 35].
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The aim of this study was to address a gap in the literature by determining the countrywide
prevalence of neurodevelopmental multimorbidity among Scottish schoolchildren and investi-
gating a wider range of associated, administratively recorded, educational outcomes: absentee-
ism, school exclusion, exam grades, and unemployment. We hypothesised that children with
neurodevelopmental multimorbidity would have poorer outcomes compared to children with
1 condition and no conditions.
Methods
This study is reported as per the Strengthening the Reporting of Observational Studies in Epi-
demiology (STROBE) guideline (S1 STROBE Checklist). While we did not publish an analysis
plan, our analyses were planned in advance of the research team accessing any data. We subse-
quently added formal mediation analyses and sensitivity analyses additionally adjusting for
comorbid physical health conditions and additional support needs at the request of the
reviewers.
Databases
Four Scotland-wide education databases were accessed via the Scottish Exchange of Educa-
tional Data (ScotXed) Unit in the Learning and Justice Directorate of the Scottish Govern-
ment: the annual Pupil Census, which includes pupils’ age, sex, ethnicity, and records of
additional support needs (referred to as special educational need in the Pupil Census); atten-
dance data including absences and exclusions which are routinely collected prospectively and
appended to the census at the end of each school year; the Scottish Qualifications Authority
(SQA) database, which records school examination results; and the School Leaver Database,
which records the education/employment status of pupils 6 months after leaving school. Two
Scotland-wide health databases were accessed via the Information Services Division (ISD) of
the NHS National Services Scotland: maternity inpatient and day case records (Scottish Mor-
bidity Record [SMR] 02), which collects maternity and obstetric data pertaining to mother and
child, and the Prescribing Information System (PIS), which contains information on all medi-
cines dispensed in the community in Scotland. These 6 databases were linked at an individual
level using a mixture of deterministic and probabilistic matching. Health records in Scotland
contain a Community Health Index (CHI) number, a unique 10-digit patient identifier
enabling health records for the same person to be linked together. The CHI database is a regis-
ter of all patients in NHS Scotland. Education records from each pupil census were probability
matched against the CHI database using sex, date of birth, and postal code, and the matched
CHI numbers were then used to deterministically match education to health data. The meth-
odology has been described in greater detail elsewhere [24, 28, 34, 36].
Case ascertainment and definition
The annual Pupil Census was used to identify any children with a record of additional support
needs due to ASD or intellectual disabilities (referred to as learning disability in the Pupil Cen-
sus). ADHD and depression were ascertained using PIS data. ADHD was defined as receipt of
at least 1 encashed prescription for atomoxetine, dexamphetamine, lisdexamphetamine, or
methylphenidate in a school year. Depression was defined as receipt of at least 1 encashed pre-
scription for a selective serotonin reuptake inhibitor (SSRI), mirtazapine, venlafaxine, or a tri-
cyclic antidepressant, in a school year. Multimorbidity was defined as 2 or more of any of
these conditions being present in the same child.
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Inclusion and exclusion criteria
Our cohort comprised children who were included on any of the pupil censuses undertaken
between 2009 and 2013 inclusive and who therefore attended a primary, secondary, or special
school in Scotland—maintained by a local authority—over that time period. Only pupils
between the ages of 4 and 19 years at the time of the Pupil Census were included. Inclusion
was restricted to singleton births due to difficulties linking the correct child for multiple births
of the same sex (S1 Fig).
Outcomes
The study included 4 outcomes: annual number of days absent from school, annual number of
school exclusions (also referred to as expulsions or suspensions) for challenging/disruptive
behaviour, academic attainment, and subsequent unemployment. The latter 2 outcomes were
restricted to pupils who left school during the study period. From 2010 onwards, the Scottish
Government only collected absence and exclusion data every 2 years, therefore these data were
only available for 2009, 2010, and 2012 and were not collected in 2011 or 2013. Attainment
was derived from the total number of examination awards achieved by each pupil at each level
of the Scottish Credit Qualifications Framework (SCQF) recorded by the SQA [37]. Attain-
ment was dichotomised as low attainment (�1 at SCQF level 2,�5 at SCQF level 3,�2
but� 7 at SCQF level 4, or>0 but�4 at SCQF level 5) or high attainment (>7 at SCQF level
4,�5 at SCQF level 5,�3 at SCQF level 6, or�1 at SCQF level 7). Unemployment was defined
as not being in employment, training, or further education 6 months after leaving school.
Covariates
We included potential sociodemographic and maternal confounders as covariates. Pupils’ sex,
ethnicity, age, and postal code of residence are recorded annually by schools for the Pupil Cen-
sus. Area socioeconomic status was derived from postal code of residence using the Scottish
Index of Multiple Deprivation (SIMD) 2012, which is derived from 38 indicators across 7
domains (income, employment, health, housing, geographic access, crime and education, and
skills and training) using information collected for data zones of residence (median population
769). Children were allocated to general population quintiles. Maternal age at delivery, parity,
maternal smoking, gestational age at delivery, mode of delivery, birth weight, and 5-minute
Apgar score were obtained from retrospective linkage to the SMR02 maternity database, and
birth weight, sex, and gestation were combined to derive sex-gestation–specific birth weight
centiles. For the purposes of employing sensitivity analyses, described in the next section, we
also identified children receiving medications for diabetes, asthma, epilepsy, and skin disor-
ders, as well as children with additional support needs attributed to the following: learning dif-
ficulty (e.g., dyslexia, dyscalculia); sensory impairment; physical motor impairment;
communication problems; social, emotional, and behavioural difficulty; physical health prob-
lems; or mental health problems.
Statistical analyses
Pupils were categorised in 2 ways. Firstly, we categorised children according to the number of
eligible conditions they had, irrespective of the actual condition (0, 1, or�2). The characteris-
tics of children with 1 condition and 2 or more conditions were compared to children with no
conditions using chi-squared tests for trend or Spearman rank correlations for ordinal data.
Outcomes experienced by children with 1 condition and 2 or more conditions were then com-
pared against children with no conditions using univariate and multivariate models. Secondly,
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we categorised children according to their specific combination of conditions. The outcomes
experienced by each category were then compared using univariate and multivariate models,
again using children with no eligible conditions as the referent group. All multivariate models
were adjusted for potential sociodemographic and maternity confounders.
Unemployment and overall attainment were analysed using binary logistic regression mod-
els. Annual number of exclusions and annual number of days absent were analysed using gen-
eralised estimating equations (GEEs) [38] with a negative binomial distribution and log link
function in order to take account of correlations between repeated measurements on the same
pupil across different school years. Different correlation structures were compared using the
quasi-likelihood under the independence model criterion (QIC) statistic [39], with the lowest
QIC indicating the most appropriate structure. The exposure time for each pupil was adjusted
using the total number of possible attendances recorded each year. For all outcomes, we tested
for statistical interactions with sex, socioeconomic deprivation, and age, and—where these
were significant—subgroup analyses were undertaken.
We explored whether absenteeism and exclusion were potential mediators of the associa-
tion between multimorbidity and academic attainment by rerunning the attainment models
including each in turn as an additional covariate. We then performed formal mediation analy-
ses using the Stata user written “paramed” command to decompose the total effect of having 2
or more conditions on attainment into direct effects (not mediated through absenteeism/
exclusion) and indirect effects (mediated through absenteeism/exclusion) adjusted for socio-
demographic and maternity factors. We used the same approach to explore whether attain-
ment was a potential mediator for unemployment. We reran the unemployment model
including attainment as a covariate and then performed formal mediation analyses to decom-
pose the total effect of having 2 or more conditions on unemployment into a direct effect (not
mediated through attainment) and an indirect effect (mediated through attainment) adjusted
for sociodemographic and maternity factors.
Finally, we carried out brief sensitivity analyses to investigate whether the main effects of
having 1 and having 2 or more conditions on each of the outcomes could be partially attrib-
uted to the associated increased risk of these affected children also having comorbid diabetes,
asthma, epilepsy, or skin disorders, or additional support needs attributed to learning difficulty
(e.g., dyslexia, dyscalculia); sensory impairment; physical motor impairment; communication
problems; social, emotional, and behavioural difficulty; physical health problems; or mental
health problems. We therefore reran the models investigating absenteeism, exclusion, attain-
ment, and unemployment and additionally adjusted them for these comorbid conditions and
any occurrence of additional support needs. All statistical analyses were conducted using Stata
MP version 14.1 (StataCorp, College Station, TX).
Approvals
Approval to undertake the study was granted by the NHS Scotland Public Benefit and Privacy
Panel. Use of the health and education data was permitted through data processing and shar-
ing agreements between the University of Glasgow, ISD, and ScotXed, respectively. The linked
data extract was anonymised, then stored and analysed within the national safe haven.
Ethics
The NHS West of Scotland Research Ethics Service confirmed that formal NHS ethics
approval was not required since the study involved anonymised extracts of routinely collected
data with an acceptably negligible risk of identification.
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Results
The study cohort comprised 2,793,185 records pertaining to 766,244 schoolchildren (S1 Fig),
of whom 35,873 (4.7%) had at least 1 of the conditions of interest and 4,789 (0.6%) had 2 or
more conditions (Table 1). Multimorbidity was more common among boys, and the preva-
lence increased with increasing deprivation. Children with multimorbidity had lower Apgar
scores, lower gestational ages, and lower birth weight centiles and were more likely to be born
via emergency cesarean section. They were more likely to be older and their mothers were
more likely to be younger, have smoked during pregnancy, and be multiparous. They were
also more likely to have comorbid diabetes, asthma, epilepsy, and skin disorders, as well as
additional support needs attributed to learning difficulty (e.g. dyslexia, dyscalculia); sensory
impairment; physical motor impairment; communication problems; social, emotional, and
behavioural difficulty; physical health problems; and mental health problems. (Table 1).
The percentage of data missing within each variable was less than 0.2% excluding parity
(0.6%), Apgar score (1.1%), ethnicity (1.8%), and smoking during pregnancy (9.9%) (Table 1).
Missing values for the latter 2 were analysed as “unknown.” Of the 10,814 children who had
ASD, 3,574 (33.0%) had at least 1 other condition. Of the 7,413 with ADHD, 2,164 (29.2%)
had at least 1 comorbidity. Of the 22,292 with intellectual disabilities, 3,685 (16.5%) had
comorbidity, and of the 5,342 with depression, 565 (10.6%) had comorbidity. The most com-
mon combination was ASD with intellectual disabilities, which occurred in 2,251 (0.3%) chil-
dren; 1,823 (81.0%) children with this combination were boys (Table 2).
Multimorbidity was associated with significantly increased risk of school absenteeism,
exclusion from school, low attainment, and subsequent unemployment with statistically signif-
icant dose relationships evident between the number of neurodevelopmental conditions (0, 1,
�2) and the last 3 outcomes (Table 3). Analyses of absenteeism and exclusion included
1,597,397 records for 702,210 children. Compared to children with none of the conditions
(median 7.5 days), children with 1 condition and children with 2 or more conditions had
more absences per year (medians 10 and 8.5 days, respectively). Compared to children with no
conditions, children with 1 condition and children with 2 or more conditions had more absen-
teeism on univariate analysis (1 condition incidence rate ratio [IRR] 1.38, 95% CI 1.36–1.39,
p< 0.001 and 2 or more conditions IRR 1.25, 95% CI 1.21–1.29, p< 0.001) and after adjust-
ment for sociodemographic and maternity confounders (1 condition adjusted IRR 1.28, 95%
CI 1.27–1.30, p< 0.001 and 2 or more conditions adjusted IRR 1.23, 95% CI 1.20–1.28, p<
0.001). There were significant interactions with sex, age, and deprivation (all p< 0.001)
whereby the magnitude of the association between multimorbidity and absenteeism was
greater in girls than boys (adjusted IRR 1.35, 95% CI 1.25–1.45, p< 0.001 versus adjusted IRR
1.20, 95% CI 1.16–1.25, p< 0.001), was stronger among children younger than 11 years of age
(adjusted IRR 1.26, 95% CI 1.21–1.32, p< 0.001) compared to children older than 14 years of
age (adjusted IRR 1.12, 95% CI 1.05–1.20, p< 0.01), and was stronger among children in the
least compared to the most deprived quintile (adjusted IRR 1.38, 95% CI 1.25–1.51, p< 0.001
versus adjusted IRR 1.06, 95% CI 1.00–1.13, p = 0.052) (Table 3). However, this latter finding
was explained by absenteeism already being higher in more deprived quintiles among children
with no morbidity; median 11.0 days versus median 5.0 days in the most and least deprived
quintiles, respectively. Among children with multimorbidity, absenteeism remained more
common in the most deprived quintile compared with the least; median 10.8 days versus
median 6.0 days, respectively (S1 Table).
Of children with 2 or more conditions, 12.8% (589/4,589) were excluded from school at
least once during the study period compared to 9.8% (3,362/34,463) of children with 1 condi-
tion and 3.5% (22,966/663,158) of children with no conditions. Compared to children with no
PLOS MEDICINE Neurodevelopmental multimorbidity and educational outcomes of Scottish schoolchildren
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003290 October 13, 2020 7 / 24
Table 1. Sociodemographic characteristics of schoolchildren with no, 1, and 2 or more neurodevelopmental conditions.
No conditions 1 condition 2 or more conditions
N = 725,582 N = 35,873 N = 4,789
n Col. % n Col. % n Col. % P value
Sociodemographic factors
Sex
Male 362,825 50.0 23,565 65.7 3,900 81.4 <0.001
Female 362,757 50.0 12,308 34.3 889 18.6
Missing 0 0 0
Average age across all school years
Mean (SD) 10.87 4.0 11.39 3.5 11.42 3.5 <0.001
Deprivation quintile
1 (most deprived) 161,875 22.3 10,590 29.6 1,329 27.8 <0.001
2 144,752 20.0 7,744 21.6 1,073 22.4
3 140,265 19.3 6,774 18.9 885 18.5
4 142,668 19.7 6,023 16.8 832 17.4
5 (least deprived) 135,470 18.7 4,702 13.1 668 14.0
Missing 552 40 2
Ethnic group
White 686,687 96.2 34,227 97.1 4,543 96.6 <0.001
Asian 16,996 2.4 630 1.8 84 1.8
Black 1,844 0.3 68 0.2 22 0.5
Mixed 6,408 0.9 244 0.7 35 0.7
Other 1,879 0.3 93 0.3 17 0.4
Missing 11,768 611 88
Maternity factors
Maternal age (years)
�24 196,112 27.0 12,192 34.0 1,574 32.9 <0.001
25–29 213,120 29.4 10,074 28.1 1,346 28.1
30–34 207,151 28.6 8,609 24.0 1,175 24.5
�35 109,187 15.1 4,998 13.9 694 14.5
Missing 12 0 0
Maternal smoking
No 468,773 72.9 19,636 61.4 2,705 63.4 <0.001
Yes 173,892 27.1 12,333 38.6 1,564 36.6
Missing 82,917 3,904 520
Parity
0 328,313 45.5 15,223 42.7 2,129 44.8 <0.001
1 250,963 34.8 11,595 32.5 1,584 33.3
>1 142,675 19.8 8,850 24.8 1,045 22.0
Missing 3,631 205 31
Mode of delivery
SVD 489,228 67.4 23,902 66.6 3,089 64.5 <0.001
Assisted vaginal 87,193 12.0 3,914 10.9 550 11.5
Breech vaginal 2,049 0.3 162 0.5 22 0.5
Elective CS 55,167 7.6 2,770 7.7 377 7.9
Emergency CS 91,784 12.7 5,121 14.3 751 15.7
Missing 161 4 0
Sex-gestation–specific birth weight centile
(Continued)
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Table 1. (Continued)
No conditions 1 condition 2 or more conditions
N = 725,582 N = 35,873 N = 4,789
n Col. % n Col. % n Col. % P value
1–3 29,020 4.0 2,187 6.1 279 5.8 <0.001
4–10 64,376 8.9 3,793 10.6 477 10.0
11–20 86,270 11.9 4,521 12.6 557 11.6
21–80 427,584 59.0 19,869 55.5 2,668 55.8
81–90 62,098 8.6 2,846 7.9 419 8.8
91–97 39,158 5.4 1,794 5.0 269 5.6
98–100 16,152 2.2 812 2.3 115 2.4
Missing 924 51 5
Gestation (weeks)
<28 905 0.1 210 0.6 39 0.8 <0.001
28–32 6,294 0.9 665 1.9 99 2.1
33–36 32,861 4.5 2,410 6.7 331 6.9
37 35,163 4.9 2,138 6.0 318 6.6
38 90,255 12.5 5,084 14.2 653 13.6
39 150,549 20.8 7,200 20.1 991 20.7
40 219,360 30.3 9,805 27.4 1,265 26.4
41 163,169 22.5 7,098 19.8 926 19.4
42 25,767 3.6 1,198 3.3 159 3.3
>42 728 0.1 37 0.1 5 0.1
Missing 531 28 3
5-minute Apgar score
1–3 3,340 0.5 331 0.9 38 0.8 <0.001
4–7 6,669 0.9 546 1.5 87 1.8
7–10 708,247 98.6 34,559 97.5 4,606 97.4
Missing 7,326 437 58
Comorbid physical conditions
Diabetes
No 722,472 99.6 35,676 99.5 4,766 99.5 <0.001
Yes 3,110 0.4 197 0.5 23 0.5
Missing 0 0 0
Asthma
No 683,082 94.1 32,881 91.7 4,381 91.5 0.003
Yes 42,500 5.9 2,992 8.3 408 8.5
Missing 0 0 0
Epilepsy
No 722,362 99.6 34,129 95.1 4,439 92.7 <0.001
Yes 3,220 0.4 1,744 4.9 350 7.3
Missing 0 0 0
Skin disorder
No 603,659 83.2 28,786 80.2 3,712 77.5 <0.001
Yes 121,923 16.8 7,087 19.8 1,077 22.5
Missing 0 0 0
ASNs
Learning difficulty
No 678,866 93.6 27,598 76.9 3,492 72.9 <0.001
(Continued)
PLOS MEDICINE Neurodevelopmental multimorbidity and educational outcomes of Scottish schoolchildren
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003290 October 13, 2020 9 / 24
conditions, children with 1 condition and children with 2 or more conditions had more exclu-
sion on univariate analysis (1 condition IRR 3.37, 95% CI 3.21–3.54, p< 0.001 and 2 or more
conditions IRR 4.55, 95% CI 4.10–5.05, p< 0.001) and after adjustment for sociodemographic
and maternity confounders (1 condition adjusted IRR 2.37, 95% CI 2.25–2.48, p< 0.001 and 2
or more conditions adjusted IRR 3.04, 95% CI 2.74–3.38, p< 0.001). There were significant
interactions with sex, age, and deprivation (all p< 0.001) whereby the magnitude of the associ-
ation between multimorbidity and exclusion was greater in girls than boys (adjusted IRR 4.34,
95% CI 3.23–5.83, p< 0.001 versus adjusted IRR 2.87, 95% CI 2.57–3.22, p< 0.001), was
stronger among children younger than 11 years of age (adjusted IRR 6.51, 95% CI 5.28–8.03,
Table 1. (Continued)
No conditions 1 condition 2 or more conditions
N = 725,582 N = 35,873 N = 4,789
n Col. % n Col. % n Col. % P value
Yes 46,716 6.4 8,275 23.1 1,297 27.1
Missing 0 0 0
Sensory impairment
No 721,438 99.4 34,158 95.2 4,479 93.5 <0.001
Yes 4,144 0.6 1,715 4.8 310 6.5
Missing 0 0 0
Physical motor impairment
No 720,772 99.3 32,997 92.0 4,199 87.7 <0.001
Yes 4,810 0.7 2,876 8.0 590 12.3
Missing 0 0 0
Communication problems
No 715,382 98.6 31,052 86.6 3,325 69.4 <0.001
Yes 10,200 1.4 4,821 13.4 1,464 30.6
Missing 0 0 0
Social, emotional, or behavioural difficulty
No 701,020 96.6 27,850 77.6 2,600 54.3 <0.001
Yes 24,562 3.4 8,023 22.4 2,189 45.7
Missing 0 0 0
Physical health condition
No 719,242 99.1 33,506 93.4 4,319 90.2 <0.001
Yes 6,340 0.9 2,367 6.6 470 9.8
Missing 0 0 0
Mental health condition
No 724,728 99.9 35,038 97.7 4,393 91.7 <0.001
Yes 854 0.1 835 2.3 396 8.3
Missing 0 0 0
Any ASN
No 644,319 88.8 18,068 50.4 1,328 27.7 <0.001
Yes 81,263 11.2 17,805 49.6 3,461 72.3
Missing 0 0 0
P values obtained using chi-squared tests for trend, Spearman rank correlation coefficients, or analysis of variance.
“Any ASN” includes those attributed to learning difficulty; sensory impairment; physical motor impairment; communication problems; social, emotional, and
behavioural difficulty; physical health problems; or mental health problems.
Abbreviations: ASN, additional support need; Col. %, column percentage; CS, cesarean section; SD, standard deviation; SVD, spontaneous vaginal delivery
https://doi.org/10.1371/journal.pmed.1003290.t001
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p< 0.001) compared to children older than 14 years of age (adjusted IRR 2.37, 95% CI 1.98–
2.82, p< 0.001), and was stronger among children in the least compared to the most deprived
quintile (adjusted IRR 4.57, 95% CI 3.16–6.63, p< 0.001 versus adjusted IRR 2.11, 95% CI
1.77–2.51, p< 0.001) (Table 3). However, this latter finding was explained by exclusion already
being higher in more deprived quintiles among children with no morbidity. The percentage of
children with no morbidity who experienced school exclusion was 6.6% (9,734/148,478) in the
most deprived quintile compared with 1.2% (1,462/123,533) in the least deprived. For children
with multimorbidity, the corresponding figures were 15.9% (202/1,269) and 7.8% (49/625),
respectively (S1 Table).
On analysing exam grades for 139,205 children, 476 (0.3%) had 2 or more conditions. The
percentage obtaining low academic attainment was higher among children with 2 or more
conditions (73.1%, 348/476) compared to children with 1 condition (57.7%, 3,436/5,953) and
children with no conditions (35.1%, 46,607/132,776). Compared to children with no condi-
tions, children with 1 condition and children with 2 or more conditions had poorer attainment
on univariate analysis (1 condition odds ratio [OR] 2.52, 95% CI 2.39–2.66, p< 0.001 and 2 or
more conditions OR 5.03, 95% CI 4.10–6.16, p< 0.001) and after adjustment for sociodemo-
graphic and maternity confounders (1 condition adjusted OR 3.92, 95% CI 3.63–4.23, p<
0.001 and 2 or more conditions adjusted OR 12.07, 95% CI 9.15–15.94, p< 0.001). There were
significant interactions with sex (p< 0.001) and deprivation (p< 0.001) whereby the magni-
tude of the association between multimorbidity and attainment was greater in girls than boys
Table 2. Number and percentage of children with each combination of condition overall and by sex, age, and deprivation quintile.
Overall Boys Girls SIMD1 most
deprived
SIMD2 SIMD3 SIMD4 SIMD5 least
deprived
Missing
SIMD
Average age
across all
school years
N = 766,244 N = 390,290 N = 375,954 N =
173,794
N =
153,569
N =
147,924
N =
149,523
N =
140,840
N = 594 N = 766,244
n % n % n % n % n % n % n % n % n Mean SD
No
conditions
725,582 94.7 362,825 93.0 362,757 96.5 161,875 93.1 144,752 94.3 140,265 94.8 142,668 95.4 135,470 96.2 552 10.87 3.99
ASD only 7,240 0.9 6,226 1.6 1,014 0.3 1,799 1.0 1,453 0.9 1,423 1.0 1,382 0.9 1,178 0.8 5 10.86 3.59
ADHD only 5,249 0.7 4,443 1.1 806 0.2 1,756 1.0 1,296 0.8 962 0.7 740 0.5 492 0.3 3 11.67 3.2
Depression
only
4,777 0.6 1,380 0.4 3,397 0.9 902 0.5 967 0.6 1,029 0.7 965 0.6 906 0.6 8 14.51 2.13
ID only 18,607 2.4 11,516 3.0 7,091 1.9 6,133 3.5 4,028 2.6 3,360 2.3 2,936 2.0 2,126 1.5 24 10.72 3.48
ASD
+ ADHD
771 0.1 704 0.2 67 0.0 204 0.1 166 0.1 149 0.1 138 0.1 114 0.1 0 11.22 3.12
ASD
+ depression
180 0.0 133 0.0 47 0.0 26 0.0 39 0.0 45 0.0 41 0.0 29 0.0 0 13.57 2.49
ADHD
+ depression
109 0.0 77 0.0 32 0.0 32 0.0 30 0.0 20 0.0 16 0.0 11 0.0 0 13.66 2.11
ID + ASD 2,251 0.3 1,823 0.5 428 0.1 622 0.4 479 0.3 422 0.3 382 0.3 346 0.2 0 10.91 3.74
ID + ADHD 939 0.1 772 0.2 167 0.0 321 0.2 230 0.1 157 0.1 143 0.1 87 0.1 1 11.60 3.09
ID
+ depression
147 0.0 65 0.0 82 0.0 36 0.0 38 0.0 30 0.0 24 0.0 19 0.0 0 13.62 2.62
Three or
more
conditions�
392 0.1 326 0.1 66 0.0 88 0.1 91 0.1 62 0.0 88 0.1 62 0.0 1 11.93 3.07
�Unable to provide numbers for specific combinations due to small numbers.
Abbreviations: ADHD, attention deficit hyperactivity disorder; ASD autism spectrum disorder; ID, intellectual disability; SIMD, Scottish Index of Multiple Deprivation
https://doi.org/10.1371/journal.pmed.1003290.t002
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Table 3. Multivariate associations between number of neurodevelopmental conditions and education outcomes: Overall and by sex, age, and deprivation quintile.
Absencea Exclusiona Low attainmentb Unemploymentc
Univariate
model
Multivariate
modeld
Univariate
model
Multivariate
modeld
Univariate
model
Multivariate
modeld
Univariate
model
Multivariate
modeld
Number of
conditions
IRR (95% CI) IRR (95% CI) OR (95% CI) OR (95% CI)
Overall None 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
One 1.38 (1.36–
1.39)
1.28 (1.27–1.30) 3.37 (3.21–
3.54)
2.37 (2.25–2.48) 2.52 (2.39–
2.66)
3.92 (3.63–4.23) 2.00 (1.90–
2.11)
1.57 (1.49–1.66)
Two or more 1.25 (1.21–
1.29)
1.23 (1.20–1.28) 4.55 (4.10–
5.05)
3.04 (2.74–3.38) 5.03 (4.10–
6.16)
12.07 (9.15–
15.94)
2.60 (2.26–
2.98)
2.11 (1.83–2.45)
Boys None 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
One 1.31 (1.29–
1.33)
1.22 (1.20–1.24) 2.90 (2.75–
3.06)
2.41 (2.29–2.55) 3.02 (2.80–
3.25)
4.51 (4.06–5.01) 1.89 (1.77–
2.02)
1.50 (1.40–1.60)
Two or more 1.22 (1.17–
1.26)
1.20 (1.16–1.25) 3.24 (2.90–
3.62)
2.87 (2.57–3.22) 4.26 (3.38–
5.35)
11.66 (8.51–
15.97)
2.29 (1.96–
2.67)
2.05 (1.74–2.41)
Girls None 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
One 1.52 (1.49–
1.55)
1.39 (1.36–1.41) 2.85 (2.54–
3.20)
2.07 (1.84–2.32) 1.98 (1.83–
2.14)
3.36 (3.01–3.77) 2.06 (1.89–
2.24)
1.77 (1.62–1.93)
Two or more 1.45 (1.34–
1.56)
1.35 (1.25–1.45) 6.01 (4.45–
8.13)
4.34 (3.23–5.83) 5.87 (3.80–
9.08)
12.57 (7.05–
22.38)
2.86 (2.11–
3.89)
2.34 (1.70–3.24)
Age <11
years
None 1.00 1.00 1.00 1.00 N/A N/A
One 1.35 (1.33–
1.37)
1.23 (1.21–1.25) 7.69 (6.93–
8.53)
4.42 (3.96–4.93) N/A N/A
Two or more 1.33 (1.28–
1.38)
1.26 (1.21–1.32) 12.01 (9.82–
14.69)
6.51 (5.28–8.03) N/A N/A
Age 11–14
years
None 1.00 1.00 1.00 1.00 N/A N/A
One 1.40 (1.38–
1.43)
1.31 (1.28–1.33) 3.07 (2.87–
3.28)
2.18 (2.04–2.33) N/A N/A
Two or more 1.30 (1.24–
1.37)
1.27 (1.21–1.34) 3.57 (3.08–
4.15)
2.47 (2.12–2.87) N/A N/A
Age >14
years
None 1.00 1.00 1.00 1.00 N/A N/A
One 1.39 (1.37–
1.42)
1.36 (1.33–1.39) 2.37 (2.19–
2.55)
1.77 (1.64–1.90) N/A N/A
Two or more 1.11 (1.04–
1.18)f
1.12 (1.05–
1.20)f
3.38 (2.85–
4.00)
2.37 (1.98–2.82) N/A N/A
SIMD cat.
1e
None 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
One 1.17 (1.15–
1.20)
1.16 (1.14–1.18) 2.47 (2.30–
2.66)
2.04 (1.89–2.19) 2.25 (2.00–
2.54)
3.22 (2.74–3.78) 1.55 (1.41–
1.69)
1.42 (1.29–1.56)
Two or more 1.01 (0.95–
1.07)g
1.06 (1.00–
1.13)h
2.84 (2.39–
3.36)
2.11 (1.77–2.51) 3.70 (2.25–
6.09)
5.11 (2.67–9.76) 1.17 (0.87–
1.57)i
1.09 (0.81–
1.48)j
SIMD cat.
2
None 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
One 1.28 (1.25–
1.31)
1.24 (1.21–1.27) 3.10 (2.82–
3.40)
2.36 (2.15–2.59) 2.27 (2.02–
2.55)
3.35 (2.84–3.94) 1.69 (1.52–
1.89)
1.44 (1.29–1.61)
Two or more 1.19 (1.11–
1.27)
1.17 (1.10–1.24) 4.31 (3.51–
5.29)
2.87 (2.35–3.52) 5.71 (3.62–
8.98)
21.58 (12.08–
38.56)
2.63 (2.01–
3.45)
2.41 (1.82–3.19)
SIMD cat.
3
None 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
One 1.41 (1.37–
1.45)
1.33 (1.30–1.37) 3.83 (3.40–
4.31)
2.77 (2.46–3.11) 2.64 (2.35–
2.96)
4.06 (3.46–4.77) 1.95 (1.72–
2.20)
1.60 (1.41–1.81)
(Continued)
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(adjusted OR 12.57, 95% CI 7.05–22.38, p< 0.001 versus adjusted OR 11.66, 95% CI 8.51–
15.97, p< 0.001) and stronger among children in the least compared to the most deprived
quintile (adjusted OR 13.65, 95% CI 6.40–29.13, p< 0.001 versus adjusted OR 5.11, 95% CI
2.67–9.76, p< 0.001) (Table 3). However, this latter finding was explained by poorer attain-
ment being more common in more deprived quintiles among children with no morbidity. The
percentage of children with no morbidity who had poor academic attainment was 54.7%
(15,682/28,658) in the most deprived quintile compared with 15.8% (3,939/24,932) in the least
deprived. For children with multimorbidity, the corresponding figures were 81.7% (85/104)
and 58.7% (37/63), respectively (S1 Table). Inclusion of days absent as a covariate attenuated
the strength of the association between multimorbidity and low attainment, but the association
remained significant (adjusted OR 11.32, 95% CI 8.48–15.10, p< 0.001). A formal mediation
analysis confirmed that the effect of multimorbidity on attainment (adjusted OR 13.84, 95%
CI 8.92–18.55, p< 0.001) was likely to be a direct effect (adjusted OR 13.50, 95% CI 8.66–
18.47, p< 0.001) rather than an indirect effect mediated by absenteeism (adjusted OR 1.02,
95% CI 0.98–1.08, p = 0.643). Inclusion of exclusions as a covariate also attenuated the strength
Table 3. (Continued)
Absencea Exclusiona Low attainmentb Unemploymentc
Univariate
model
Multivariate
modeld
Univariate
model
Multivariate
modeld
Univariate
model
Multivariate
modeld
Univariate
model
Multivariate
modeld
Number of
conditions
IRR (95% CI) IRR (95% CI) OR (95% CI) OR (95% CI)
Two or more 1.37 (1.28–
1.47)
1.35 (1.25–1.45) 5.72 (4.49–
7.28)
3.94 (3.08–5.04) 4.38 (2.88–
6.66)
11.01 (6.33–
19.16)
2.80 (2.05–
3.82)
2.46 (1.77–3.40)
SIMD cat.
4
None 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
One 1.43 (1.39–
1.47)
1.36 (1.32–1.40) 3.84 (3.31–
4.44)
2.79 (2.40–3.24) 2.98 (2.63–
3.36)
5.37 (4.50–6.40) 2.62 (2.28–
3.00)
2.21 (1.92–2.55)
Two or more 1.38 (1.27–
1.49)
1.35 (1.25–1.45) 8.07 (6.14–
10.60)
5.19 (3.91–6.88) 5.91 (3.75–
9.33)
12.64 (6.95–
23.02)
4.97 (3.58–
6.88)
4.06 (2.89–5.70)
SIMD cat.
5e
None 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
One 1.57 (1.52–
1.63)
1.46 (1.41–1.51) 4.91 (4.05–
5.94)
3.26 (2.69–3.95) 2.87 (2.49–
3.31)
4.17 (3.41–5.11) 2.96 (2.51–
3.49)
2.47 (2.08–2.93)
Two or more 1.40 (1.27–
1.54)
1.38 (1.25–1.51) 7.71 (5.39–
11.01)
4.57 (3.16–6.63) 7.58 (4.59–
12.54)
13.65 (6.40–
29.13)
4.78 (3.24–
7.04)
4.17 (2.79–6.23)
a1,597,397 records (702,018 pupils) analysed using GEEs with a negative binomial distribution and log link function to produce IRRs.
b139,205 pupils analysed using binary logistic regression to produce ORs.
c217,924 pupils analysed using binary logistic regression to produce ORs.
dAll multivariate models adjusted for age, sex, deprivation quintile, ethnic group, maternal age, maternal smoking, parity, mode of delivery, gestation at delivery, sex-
gestation–specific birth weight centile, and 5-minute Apgar score.
eSIMD cat. 1 = most deprived; SIMD cat 5 = least deprived.
fp< 0.01.
gp = 0.799.
hp = 0.052.
ip = 0.299.
jp = 0.570.
All models significant at p< 0.001 except for those indicated with a footnote. “N/A” indicates that subgroup analyses didn’t apply as all children in these analyses were
aged 14 years or older.
Abbreviations: cat., category; GEE, generalised estimating equation; IRR, incidence rate ratio; OR, odds ratio; SIMD, Scottish Index of Multiple Deprivation
https://doi.org/10.1371/journal.pmed.1003290.t003
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of the association between multimorbidity and low attainment, but again the association
remained significant (adjusted OR 10.69, 95% CI 8.04–14.20, p< 0.001). A formal mediation
analysis suggested that most of the effect of multimorbidity on attainment (adjusted OR 14.08,
95% CI 9.00–19.65, p< 0.001) was a direct effect (adjusted OR 11.14, 95% CI 7.33–15.47, p<
0.001) with a small portion attributed to an indirect effect mediated by exclusion (adjusted OR
1.26, 95% CI 1.20–1.36, p< 0.001).
Of 217,924 children leaving school over the study period, 1,164 (0.5%) had 2 or more condi-
tions. Unemployment was higher among children with 2 or more conditions (22.3%, 260/
1,164) compared to children with 1 condition (18.1%, 1,874/10,333) and children with no con-
ditions (10.0%, 20,585/206,427). Compared to children with no conditions, children with 1
condition and children with 2 or more conditions had increased unemployment on univariate
analysis (1 condition OR 2.00, 95% CI 1.90–2.11, p< 0.001 and 2 or more conditions OR 2.60,
95% CI 2.26–2.98, p< 0.001) and after adjustment for sociodemographic and maternity con-
founders (1 condition adjusted OR 1.57, 95% CI 1.49–1.66, p< 0.001 and 2 or more condi-
tions adjusted OR 2.11, 95% CI 1.83–2.45, p< 0.001). There was a significant interaction with
deprivation (p< 0.001) whereby there was a significant association between multimorbidity
and unemployment among children in the least deprived quintile but not for children in the
most deprived quintile (adjusted OR 4.17, 95% CI 2.79–6.23, p< 0.001 versus adjusted OR
1.09, 95% CI 0.81–1.48, p = 0.570) (Table 3). However, this was explained by unemployment
being higher in more deprived quintiles among children with no morbidity. The percentage of
children with no morbidity who were unemployed 6 months after leaving school was 16.5%
(7,431/45,009) in the most deprived quintile compared with 4.7% (1,831/39,269) in the least
deprived. For children with multimorbidity, the corresponding figures were 18.8% (55/293)
and 18.9% (32/169), respectively (S1 Table). Following inclusion of attainment as a covariate,
the association between multimorbidity and unemployment was no longer statistically signifi-
cant (adjusted OR 1.13, 95% CI 0.87–1.48, p = 0.368). A formal mediation analysis confirmed
that the effect of multimorbidity on unemployment (adjusted OR 2.16, 95% CI 1.56–2.78, p<
0.001) was likely to be an indirect effect mediated by attainment (adjusted OR 1.91, 95% CI
1.77–2.02, p< 0.001) rather than a direct effect (adjusted OR 1.13, 95% CI 0.84–1.48,
p = 0.359).
On sensitivity analyses, the main associations between multimorbidity and each of the out-
comes (absences, exclusions, attainment, and unemployment) remained, and the effect sizes
were of similar magnitude as before. This suggested that the associations were irrespective of
the increased physical comorbidities and additional support needs experienced by these
affected children (Table 4).
On analysing specific combinations of the 4 neurodevelopmental conditions of interest ver-
sus children with no conditions, we observed that the strongest driver of absenteeism was
coexistence of depression. The unadjusted and adjusted IRRs were 1.01 (95% CI 0.98–1.04
[p = 0.529]) and 1.10 (95% CI 1.08–1.13 [p< 0.001]), respectively, for isolated ASD; 1.43 (95%
CI 1.39–1.47 [p< 0.001]) and 1.20 (95% CI 1.17–1.23 [p< 0.001]), respectively, for isolated
ADHD; and 1.28 (95% CI 1.26–1.30 [p< 0.001]) and 1.20 (95% CI 1.18–1.22 [p< 0.001]),
respectively, for isolated intellectual disabilities. For children with concomitant depression, the
corresponding figures were 2.30 (95% CI 1.99–2.66 [p< 0.001]) and 2.36 (95% CI 2.01–2.76 [p
< 0.001]), 2.57 (95% CI 2.13–3.09 [p< 0.001]) and 2.16 (95% CI 1.79–2.62 [p< 0.001]), and
2.37 (95% CI 2.06–2.74 [p< 0.001]) and 1.99 (95% CI 1.71–2.31 [p< 0.001]), respectively (Fig
1). The strongest driver of exclusion from school was coexistence of ADHD. The unadjusted
and adjusted IRRs were 1.81 (95% CI 1.57–2.08 [p< 0.001]) and 1.50 (95% CI 1.30–1.73 [p<
0.001]), respectively, for isolated ASD; 1.74 (95% CI 1.48–2.04 [p< 0.001]) and 1.52 (95% CI
1.30–1.78 [p< 0.001]), respectively, for isolated depression; and 2.07 (95% CI 1.91–2.24 [p<
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0.001]) and 1.46 (95% CI 1.35–1.58 [p< 0.001]), respectively, for isolated intellectual disabili-
ties. For children with concomitant ADHD, these increased to 7.96 (95% CI 6.59–9.60 [p<
0.001]) and 6.04 (95% CI 4.98–7.33 [p< 0.001]), 9.73 (95% CI 6.31–14.99 [p< 0.001]) and
5.37 (95% CI 3.40–8.49 [p< 0.001]), and 9.01 (95% CI 7.67–10.58 [p< 0.001]) and 4.58 (95%
CI 3.87–5.43 [p< 0.001]), respectively (Fig 2). The associations with low attainment and
unemployment did not appear to be driven by specific conditions; rather they displayed non-
specific dose relationships whereby increasing numbers of concomitant conditions were asso-
ciated with increased risk (S2 and S3 Figs).
Discussion
We retrospectively linked Scotland-wide education and health data to analyse outcomes
among 766,244 children attending Scottish schools between 2009 and 2013. We ascertained
ASD and intellectual disabilities from records of additional support needs and ADHD and
depression through relevant encashed prescriptions and identified children with neurodeve-
lopmental multimorbidity (�2 of these conditions) before comparing them against peers.
Children with multimorbidity fared worse across all the educational outcomes measured,
experiencing greater absenteeism and exclusion, poorer attainment, and increased unemploy-
ment even after adjusting for sociodemographic and maternity factors, comorbid physical
Table 4. Multivariate associations between number of neurodevelopmental conditions and education outcomes: Sensitivity analyses adjusting for physical comor-
bidities and additional support needs.
Absencea Exclusiona Low
attainmentb
Unemploymentc
Number of
conditions
IRR (95%
CI)
IRR (95% CI) OR (95% CI) OR (95% CI)
Adjusted for sociodemographic and maternity factorsd None 1.00 1.00 1.00 1.00
One 1.28 (1.27–
1.30)
2.37 (2.25–
2.48)
3.92 (3.63–
4.23)
1.57 (1.49–1.66)
Two or more 1.23 (1.20–
1.28)
3.04 (2.74–
3.38)
12.07 (9.15–
15.94)
2.11 (1.83–2.45)
Adjusted for sociodemographic and maternity factorsd and comorbid
physical conditionse
None 1.00 1.00 1.00 1.00
One 1.26 (1.25–
1.28)
2.40 (2.28–
2.52)
3.80 (3.52–
4.10)
1.54 (1.46–1.63)
Two or more 1.21 (1.17–
1.25)
3.12 (2.81–
3.47)
11.80 (8.94–
15.58)
2.04 (1.76–2.36)
Adjusted for sociodemographic and maternity factorsd, comorbid physical
conditionse, and any record of additional support needsf
None 1.00 1.00 1.00 1.00
One 1.22 (1.21–
1.23)
1.83 (1.74–
1.93)
3.16 (2.92–
3.42)
1.48 (1.40–1.57)
Two or more 1.13 (1.09–
1.17)
2.05 (1.84–
2.28)
7.42 (5.58–
9.86)
1.89 (1.63–2.19)
a1,597,397 records (702,018 pupils) analysed using GEEs with a negative binomial distribution and log link function to produce IRRs.
b139,205 pupils analysed using binary logistic regression to produce ORs.
c217,924 pupils analysed using binary logistic regression to produce ORs.
dAdjusted for age, sex, deprivation quintile, ethnic group, maternal age, maternal smoking, parity, mode of delivery, gestation at delivery, sex- gestation–specific birth
weight centile, and 5-minute Apgar score.
eAdjusted for diabetes, asthma, epilepsy, and skin disorders.
fAdjusted for any additional support needs attributable to learning difficulty, sensory impairment, physical motor impairment, communication problems, social,
emotional, and behavioural difficulty, physical health problems, and mental health problems.
All models significant at p< 0.001.
Abbreviations: GEE, generalised estimating equation; IRR, incidence rate ratio; OR, odds ratio
https://doi.org/10.1371/journal.pmed.1003290.t004
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conditions, and additional support needs. Significant dose relationships were evident between
number of conditions (0, 1,�2) and the last 3 outcomes. Girls were less likely to have multi-
morbidity but experienced greater adverse impact on educational outcomes than boys if they
did. Multimorbidity most commonly took the form of coexisting ASD and intellectual disabil-
ity. ADHD, on its own or coexisting with other conditions, was the strongest observed driver
behind increased exclusion from school. Depression was less common, but when present, it
was the strongest observed driver of school absenteeism. Low attainment and unemployment
were less susceptible to specific conditions; rather they were more common among children
with multimorbidity independent of the specific combination of conditions. The association
between multimorbidity and attainment was a direct effect not mediated by absenteeism but
partially mediated by exclusion. The association between multimorbidity and unemployment
was an indirect effect mediated through poorer attainment.
Our findings fill a gap in previous research regarding neurodevelopmental multimorbidity
in children. Previous studies investigating singular or comorbid neurodevelopmental condi-
tions have used small cohorts, whereas larger studies have focussed on educational outcomes
Fig 1. Associations between different combinations of neurodevelopmental conditions and absenteeism. Adjusted
for age, sex, deprivation quintile, ethnic group, maternal age, maternal smoking, parity, mode of delivery, gestation at
delivery, sex-gestation–specific birth weight centile, and 5-minute Apgar score. All categories referent to children with
no conditions. 1,597,397 records (702,018 pupils) analysed using GEEs with a negative binomial distribution and log
link function to produce IRRs. Bars represent 95% confidence intervals. All models significant at p< 0.001 except ap<
0.01; bp = 0.055; cp = 0.165. ADHD, attention deficit hyperactivity disorder; ASD, autism spectrum disorder; D,
depression; GEE, generalised estimating equation; ID, intellectual disability; IRR, incidence rate ratio.
https://doi.org/10.1371/journal.pmed.1003290.g001
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associated with single conditions, such as our own work on ADHD and depression [24, 28,
34]. To our knowledge, no previous studies in Scotland, the UK, or worldwide have investi-
gated the associations between neurodevelopmental multimorbidity and measurable educa-
tional outcomes in an unselected, population-wide cohort. Our study was a large, nonselective
study including children across the whole of Scotland. However, to enable our results to be
more widely generalizable, the study findings should be corroborated in other countries where
there may be differences in educational support.
Previous smaller sample studies that have investigated school outcomes of children with co-
occurring conditions have mainly focussed on comorbid ADHD with respect to academic
attainment using battery tests [32] or parental, teacher, or pupil feedback [31, 33, 35] and have
reported poorer outcomes in these children. These studies reported outcomes of children with
ADHD and comorbid ASD [31], depression [32], and learning difficulty (e.g. dyslexia, dyscal-
culia) [33,35]. Our findings of poorer academic attainment based on school recorded exam
results agree with these studies on children with comorbid ADHD and ASD, and on children
with comorbid ADHD and depression.
Fig 2. Associations between different combinations of neurodevelopmental conditions and exclusion. Adjusted for
age, sex, deprivation quintile, ethnic group, maternal age, maternal smoking, parity, mode of delivery, gestation at
delivery, sex-gestation–specific birth weight centile, and 5minute Apgar score. All categories referent to children with
no conditions. 1,597,397 records (702,018 pupils) analysed using GEEs with a negative binomial distribution and log
link function to produce IRRs. Bars represent 95% confidence intervals. All models significant at p< 0.001 except ap<
0.05; bp = 0.088; cp = 0.300; dp = 0.631. ADHD, attention deficit hyperactivity disorder; ASD, autism spectrum
disorder; D, depression; GEE, generalised estimating equation; ID, intellectual disability; IRR, incidence rate ratio.
https://doi.org/10.1371/journal.pmed.1003290.g002
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We observed some sex differences both in terms of prevalence of conditions, in combina-
tion or in isolation, and in terms of how these conditions affected the outcomes. Schools may
have a lower awareness or experience of ASD in girls particularly given that the prevalence is 3
times higher in boys [40]. Previous research suggests that female presentation of ASD may dif-
fer from that in males and may not be as well detected by standard measures [41, 42]. ASD in
females of average intelligence may be “masked” by other conditions, such as eating disorders
[43], anxiety disorders, and borderline personality disorders [44]. Females with ASD may be
better than males at hiding their difficulties by copying social interaction and having better
language skills, different special interests, and less hyperactivity and aggression [45, 46]. While
depression is more common in girls [47], affected boys are more likely to exhibit violence and
misbehaviour, whereas girls are more likely to withdraw or experience less visible symptoms
such as sleep problems, eating disorders, reduced motivation, and self-harm [48]. Therefore,
schools may be less likely to recognise girls as needing support. Similarly, girls who have
ADHD more often present with subtle symptoms such as inattention, whereas boys more
commonly present with impulsivity and hyperactivity [49]. Girls are both less likely to have a
referral for medical assessment and less likely to use medication [49, 50]. This may explain
why girls with known ADHD have a significantly higher rate of exclusion than boys with the
condition [24, 34].
Multimorbidity was more likely to result in exclusion in younger children and absenteeism
in older children. Underlying disorders may be less well recognised or managed in younger
pupils, and therefore disruptive behaviours more commonly result in exclusions. Another fac-
tor may be that older children have greater autonomy and less parental control and are, there-
fore, more able to personally choose to be absent from school. We observed that the most
commonly occurring combination of conditions was intellectual disability and autism. This
concurs with previous literature, and there is evidence of shared genetics [51]. Children with
autism have a wide range of intellectual abilities, ranging from children with severe intellectual
disabilities to those with above normal intellectual abilities. On balance, we felt it best to pres-
ent children with and without intellectual disabilities separately.
We observed that children with neurodevelopmental comorbidity also had increased preva-
lence of physical disorders such as diabetes, asthma, epilepsy, and skin disorders, as well as
increased risk of having additional support needs attributed to learning difficulty (e.g., dys-
lexia, dyscalculia); sensory impairment; physical motor impairment; communication prob-
lems; social, emotional, and behavioural difficulty; physical health problems; and mental
health problems. The association with comorbid epilepsy is not surprising and is likely attrib-
utable to the previously reported high prevalence among people with intellectual disability [52,
53]. The increased prevalence of diabetes, asthma, and skin disorders such as psoriasis among
children with neurodevelopmental disorders has also been reported elsewhere [53]. In addi-
tion to poorer educational outcomes, including increased additional support needs, among
children treated for ADHD and depression, we have also previously reported poorer school
outcomes among children treated for diabetes, asthma, and epilepsy [54–56]. Increased addi-
tional support needs is not surprising given that these children may require assistance due to
wider comorbidities or symptoms directly related to their combination of conditions. Results
from our sensitivity analyses, however, suggest that the observed associations between neuro-
developmental multimorbidity and absenteeism, exclusion, attainment, and unemployment
were irrespective of the existence of comorbid physical conditions and other reasons for addi-
tional support needs.
Our study had several strengths. Our cohort of 766,244 pupils was population-wide and
provided enough statistical power to test for interactions and conduct subgroup analyses
where appropriate. We were able to adjust for a range of sociodemographic—as well as
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maternal and pregnancy related—confounders identified through linkage to maternity rec-
ords, and we were able to identify comorbid physical conditions and additional support needs
to enable sensitivity analyses. The 4 school outcomes share potential associations of their own.
For example, repeated exclusions contribute directly to days absent from school, absences and
exclusions negatively affect attainment, and school performance influences future employment
opportunities. We have highlighted some of these associations previously [55]. Therefore, to
account for and better explain the intricacies of these relationships, we used robust mediation
modelling in order to decompose main effects into direct and indirect effects. Identification of
affected children through school records and community prescriptions, rather than hospital
attendance, reduced the likelihood of ascertainment being restricted to more severe cases with
the exception of depression since psychological interventions rather than antidepressants are
the first-line treatments in depressed children and adolescents. Missing data across all covari-
ates did not exceed 1.9% and, for most analyses, was considerably lower. Given the sample
size, we do not believe this affected the results, and therefore we did not impute data or run
sensitivity analyses.
Nevertheless, there were also some limitations. Our ascertainment methods failed to
include children not yet diagnosed, children diagnosed but not receiving treatment for
ADHD, and children either not receiving treatment or receiving solely nonmedicinal treat-
ments such as cognitive behavioural therapy for depression. Conversely, over-ascertainment
may have occurred due to the nonspecific nature of some of the medications. In particular, we
ascertained depression using encashed prescriptions for tricyclic antidepressants, SSRIs, mirta-
zapine, or venlafaxine. Some of these drugs have other indications such as OCD, anxiety disor-
ders, irritability, or enuresis, and without primary care records, we could not confirm the
clinical indications for medication. However, these conditions often occur in conjunction with
depression, and the prevalence of enuresis was low in the age range studied. Furthermore, pre-
vious studies report that depression is the main reason for prescribing SSRI antidepressants
[57–60], and we previously demonstrated poorer education and health outcomes associated
with antidepressants regardless of whether ascertainment was based on the classification
described above or whether solely fluoxetine and citalopram were prescribed, the recom-
mended first- and second-line treatments for depression in children and adolescents in the
UK [28]. A previous study demonstrated that 62.4% and 62.2% of children prescribed fluoxe-
tine and citalopram did have depression [58]. Medications for ADHD are more specific, but
common comorbidities such as oppositional defiant disorder and conduct disorder may still
exist, and we could not identify these in our cohort. Our sensitivity analyses, however, did
adjust for additional support needs, which includes needs attributed to social, emotional, and
behavioural issues. We used existing, administrative databases established for other purposes.
However, they undergo regular quality assurance checks, and while the linkage between educa-
tion and health records used probabilistic matching, we have previously shown this to be 99%
accurate for singletons [36]. The study included only local-authority schools, but in Scotland,
only 5% of children attend private schools. According to the 2011 Scottish Census, 11% of
Scottish residents aged 5–19 years were born outside of Scotland, consistent with the 12.3% of
Scottish children we could not link to Scottish maternity records. Prevalence of any (4.3%) and
2 or more (0.6%) of those conditions was similar in pupils who did not link versus those who
did (4.7% and 0.6%, respectively). Finally, while we identified whether children did or did not
have intellectual disabilities, we had no further information on their level of cognitive abilities.
The introduction of treatment plans is welcome as an attempt to provide children with
more personalised healthcare. However, the situation is still not perfect, and more progress is
required. There remain aspects of structural organisation and process within healthcare as well
as social care and education that are not conducive to holistic management. For example,
PLOS MEDICINE Neurodevelopmental multimorbidity and educational outcomes of Scottish schoolchildren
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003290 October 13, 2020 19 / 24
clinical training, clinical guidelines, and clinical trials are structured around individual condi-
tions, and as such, children are likely to have their conditions managed by different physicians.
For example, epilepsy may be treated at a neurology clinic, whereas a community paediatrician
or child psychiatrist may treat ADHD. Many charities also still focus on individual conditions
such as epilepsy or ASD. Given that these children also experience comorbid physical condi-
tions, a more joined-up approach to care is required. Additionally, further studies could use-
fully attempt to disentangle whether all children with neurodevelopmental multimorbidity
benefit from more comprehensive treatment plans and a more joined-up approach to care, as
well as the extent to which any benefits relate to the extent of cognitive abilities of the children
in the different multimorbidity groupings. Such studies could inform what interventions are
most relevant to increase school attendance, and for which groups of individuals.
Conclusion
Our study found that, compared to their peers, children with neurodevelopmental multimor-
bidity fared worse across all of the educational outcomes measured, experiencing greater
absenteeism and exclusion, poorer attainment, and increased unemployment even after
adjusting for sociodemographic and maternity factors, comorbid physical conditions, and
additional support needs. Based on these findings, our study suggests that focussing healthcare
systems and training on individual neurodevelopmental conditions may disadvantage children
with neurodevelopmental multimorbidity by failing to recognise and address all of their needs.
Early diagnosis and earlier intervention extending beyond the health sector into schools is
needed to minimise long-term adverse outcomes. This could be in the form of additional sup-
port programmes that aim to reduce the risk of adverse outcomes in at-risk groups. We found
that the increased risk of poor exam results was in part explained by higher rates of exclusion
from school, and that poorer exam results, in turn, explained increased risk of unemployment.
We acknowledge that, in our study, we did not know whether children with neurodevelop-
mental multimorbidity had lower cognitive abilities than children with single conditions, or
whether certain groupings of neurodevelopmental multimorbidity were associated with lower
cognitive abilities to a greater extent than other groupings. Furthermore, we do not know
whether children’s educational and occupational outcomes would benefit from intervention to
the same or to a lesser extent if they have lower cognitive abilities. While acknowledging these
uncertainties, we conclude that efforts should focus on interventions that can improve aca-
demic attainment and reduce absence and exclusion—or their respective impact—on affected
children.
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S1 Table. Summary outcomes among least and most deprived children with neurodevelop-
mental multimorbidity and no morbidity.
(DOCX)
S1 Fig. Flow diagram illustrating the number of pupils included and excluded from the
cohort at each stage of data cleaning.
(TIF)
S2 Fig. Associations between different combinations of neurodevelopmental conditions
and attainment. Adjusted for age, sex, deprivation quintile, ethnic group, maternal age,
maternal smoking, parity, mode of delivery, gestation at delivery, sex-gestation–specific birth
weight centile, and 5-minute Apgar score. All categories referent to children with no condi-
tions. 139,205 pupils analysed using binary logistic regression to produce ORs. Bars represent
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95% confidence intervals. All models significant at p< 0.001. ADHD, attention deficit hyper-
activity disorder; ASD, autism spectrum disorder; D, depression; ID, intellectual disability;
OR, odds ratio.
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S3 Fig. Associations between different combinations of neurodevelopmental conditions
and unemployment. Adjusted for age, sex, deprivation quintile, ethnic group, maternal age,
maternal smoking, parity, mode of delivery, gestation at delivery, sex-gestation–specific birth
weight centile, and 5-minute Apgar score. All categories referent to children with no condi-
tions. 217,924 pupils analysed using binary logistic regression to produce ORs. Bars represent
95% confidence intervals. All models significant at p< 0.001 except ap< 0.01; bp< 0.05;
cp = 0.051; dp = 0.052; ep = 0.149; fp = 0.419; gp = 0.809. ADHD, attention deficit hyperactivity
disorder; ASD, autism spectrum disorder; D, depression; ID, intellectual disability; OR, odds
ratio.
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